131 related articles for article (PubMed ID: 8187355)
1. Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.
Wanner C; Böhler J; Eckardt HG; Wieland H; Schollmeyer P
Clin Nephrol; 1994 Mar; 41(3):138-43. PubMed ID: 8187355
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
[TBL] [Abstract][Full Text] [Related]
3. [Effect of a long-term treatment with simvastatin, an inhibitor of HMG-CoA reductase, in dyslipidemic patients at high risk].
Strano A; Novo S; Notarbartolo A; Davì G; Abrignani MG; Alaimo G; Averna MR; Barbagallo CM; Marino G
Cardiologia; 1989 Dec; 34(12):1027-33. PubMed ID: 2634479
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.
Prata MM; Nogueira AC; Pinto JR; Correia AM; Vicente O; Rodrigues MC; Miguel MJ
Clin Nephrol; 1994 May; 41(5):277-83. PubMed ID: 8050207
[TBL] [Abstract][Full Text] [Related]
5. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
[TBL] [Abstract][Full Text] [Related]
6. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
Park S; Kang HJ; Rim SJ; Ha JW; Oh BH; Chung N; Cho SY
Clin Ther; 2005 Jul; 27(7):1074-82. PubMed ID: 16154486
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
8. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
9. [The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels].
Pirat B; Korkmaz ME; Eroğlu S; Tayfun E; Yildirir A; Uluçam M; Ozin B; Müderrisoğlu H
Anadolu Kardiyol Derg; 2004 Dec; 4(4):318-22. PubMed ID: 15590360
[TBL] [Abstract][Full Text] [Related]
10. A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone.
Rayner BL; Byrne MJ; van Zyl Smit R
Clin Nephrol; 1996 Oct; 46(4):219-24. PubMed ID: 8905205
[TBL] [Abstract][Full Text] [Related]
11. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
Ide H; Fujiya S; Aanuma Y; Agishi Y
Clin Ther; 1990; 12(5):410-20. PubMed ID: 2268863
[TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.
Joy MS; Dornbrook-Lavender KA; Chin H; Hogan SL; Denu-Ciocca C
Ann Pharmacother; 2008 Jan; 42(1):9-15. PubMed ID: 18000162
[TBL] [Abstract][Full Text] [Related]
13. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
Pappu AS; Bacon SP; Illingworth DR
J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
Gansevoort RT; Heeg JE; Dikkeschei FD; de Zeeuw D; de Jong PE; Dullaart RP
Nephrol Dial Transplant; 1994; 9(3):244-50. PubMed ID: 8052429
[TBL] [Abstract][Full Text] [Related]
17. Effects of simvastatin on the number and composition of apoproteinB-containing lipoproteins in hypercholesterolemia: analysis of apoproteinB in each lipoprotein fraction by highly sensitive latex method.
Ikeda Ryomoto K; Suzuki M; Tsushima M; Yamamoto A; Harano Y
Endocr J; 1996 Oct; 43(5):469-75. PubMed ID: 8980885
[TBL] [Abstract][Full Text] [Related]
18. Effect of simvastatin on qualitative and quantitative changes of lipoprotein metabolism in CAPD patients.
Wanner C; Lubrich-Birkner I; Summ O; Wieland H; Schollmeyer P
Nephron; 1992; 62(1):40-6. PubMed ID: 1436290
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
[TBL] [Abstract][Full Text] [Related]
20. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]